Professor Of Oncology resume example with 20+ years of experience
JessicaClaire
Montgomery Street, San Francisco, CA94105609 Johnson Ave., 49204, Tulsa, OK
H: (555) 432-1000
C:
resumesample@example.com
Date of Birth:
India:
:
single:
Professional Summary
Personable Oncology Physician who excels in high-stress environments. Focused on putting patients at ease and clearly diagnosing even the most difficult cases.
Licenses
PhD Clinical Oncology, MSc Clinical Oncology, MBBCh of Medicine and Surgery
Skill Highlights
Good bedside manner
Quality assurance awareness
Decision-making under pressure
High ethical standards
Collaborative
Level-headed
Practice-based learning
Adult Medical Oncology Consultant
Professor of Oncology
Professional Experience
Professor of Oncology, 09/2015 - 03/2016 New Mexico State University – Las Cruces, NM, Egypt
Improved performance at the organizational, departmental and individual levels.
Rapidly assessed and responded to medical emergencies.
Specialized in the diagnosis, treatment and management of brain and nervous system disorders.
Discussed various treatment options extensively with patients and families.
Assistant Professor, 05/2008 - 09/2015 University Of Texas At Austin – Austin, TX, In the Center of Clinical Oncology and Nuclear Medicine (NEMROCK), Faculty of Medicine, Cairo University from June 2008 till October 2015, Egypt.
Lecturer, 04/2002 - 06/2008 Faculty Of Medicine – City, STATE,
In the Center of Clinical Oncology and Nuclear Medicine (NEMROCK), Faculty of Medicine, Cairo University from May 2002 till July 2008, Egypt.
Assistant Lecturer, 06/1997 - 04/2002 Faculty Of Medicine – City, STATE,
In the Center of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Cairo University from July 1997 till May 2002, Egypt.
Oncology Fellow, 08/1983 - 08/1986 Faculty Of Medicine – City, STATE,
Faculty of Medicine, Cairo University from September 1993 to September 1996, Egypt.
Education and Training
MBBCh: Medicine and Surgery, Expected in 1991 - Kasr El-Aini School of Medicine - Cairo, Kasr El-Aini GPA: MBBCh of Medicine and Surgery
MSc: Oncology, Expected in 1996 - Kasr El-Aini School of Medicine - Cairo, Kasr El-Aini GPA:
Master degree in Oncology
Thesis title: "Clinico-epidemiologic study of Colorectal cancer in Egypt" (Retrospective study). *M.B.B.Ch. Faculty of Medicine, Kasr El-Aini, Cairo University in December, 1991 and was signed excellent.
Ph.D.: Oncology, Expected in 2001 - Kasr El-Aini School of Medicine - Cairo, Kasr El-Aini GPA:
Dectorate in Oncology
Thesis
Title: “Comparative Study between Conventional Simulation
and CT attached Simulation in Irradiation of Pelvic Malignancies” (Prospective
Study).
In Clinical Oncology (Radiation Therapy and Medical Oncology), Faculty of Medicine, Kasr El-Aini, Cairo University in November, 1996 and was graded good.: , Expected in - - , GPA:
Community Service
Community education for early detection of cancer
Outreach program
Accomplishments
National and International publications in the field
Skillfully treated high risk cancer patients
Professional Affiliations
American Society of Oncology (ASCO)
European Society of Medical Oncology
Egyptian Medical Syndicate
Egyptian Cancer Society
Saudi Council of Health Specialities (SCHS)
Saudi Cancer Foundation (SCF)
Publications
1. The predictive role of pretreatment 18
F-FDG (PET/CT) maximum standardized uptake value in multiple or oligometastatic
breast cancer patients: J Nucl Med Radiat Ther, 2015: Volume 6
• Issue 4 • 1000236 ISSN: 2155-9619 JNMRT, an open access journal.
Oral presentation at the RSNA 100th Scientific
Assembly and Annual Meeting, November 30 to December 5, 2014 at McCormick
Place, Chicago, IL. Public ID: SSK23-02 Time: 3 Dec 2014 10:40 AM.
2. Correlation of
preoperative ki 67 and CA 15.3 levels with the outcome in early breast cancer.
A multi institutional study: Poster presentation at 18 th ECCO
– 40 th ESMO European cancer congress, Vienna, Austria, 28 septemper 2015 from
9:15 – 11:15.
3. EGFR Inhibitors in Treatment of
Lung Adenocarcinoma: Kasr El-aini J. Clin. Oncol.and nucl. Med, July 2014.
4. Plasma
EBV DNA concentration correlates with FDG PET in Nasopharyngeal carcinoma
treated with induction chemotherapy: Poster
presentation in ESMO published in Annals of Oncology, volume 23, Sept 2012
Supplement 9.
5. Epidemiology and Clinical Features of Renal Cell
Carcinoma, Experience of Single Institute: Abstract in Best of ASCO held in Cairo, Egypt, 20-21
Sept 2012.
6. Preoperative Concurrent Chemoradiation for Patients
with Rectal cancer, Experience of a Single Institute: Oral presentation in Best of ASCO held in Dammam,
KSA, 12-13 Sept 2012.
7. Survival of patients with
locally advanced triple-negative breast cancer after neoadjuvant
platinum-containing chemotherapy: Experience of a single institute: Abstract
published in J Clin Oncol 29,
2011 (suppl 27; abstr 274).
8. Neoadjuvant platinum
containing regimen for locally advanced triple negative breast cancer: Abstract
published in ECCO 16 – 35th ESMO Congress, Milan 8-12 October 2010.
9. Clinical and Pathological
assessment of response of locally advanced breast Cancer to upfront triplet
combination chemotherapy (Docetaxel, Epirubicin and Cyclophosphamide): Phase II Study, BMJ Middle East, Vol 16 No 172 ISSN 1106 5028, June 2009.
10. HER-2 Positive
Locally Advanced Breast Cancer: One or
Two entities? Poster presentation
in ECCO 15 – 34th ESMO Congress 20-24 September, Berlin 2009.
11. What is the optimal duration of Folfox and
Bevacizumab in metastatic Colorectal Cancer, Annals of Oncology,
Vol 19, Suppl 3, May 2008.
12. Clinical and
Pathological Assessment of Response of Locally advanced Breast Cancer to
Upfront Triplet Combination Chemotherapy (Docetaxel, Epirubicin and
Cyclophosphamide): PHASE II STUDY, Kasr El Aini Journal of
Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Cairo
University, May 2008.
13. Kasr El-Aini
Experience in Radiation Safety and Quality Management Program in Intravascular
Brachytherapy: Poster
presentation in 16th International Conference on Medical Physics
(ICMP 2008), Dubai,
April 14-16, 2008, UAE.
14. What is the
optimum duration of FOLFOX-Bevacizumab in metastatic colorectal cancer (CRC):
Abstract accepted for Poster
presentation in 6th International Symposium on Targeted
Anticancer Therapies (TAT 2008), Bethesda, MD, March 20-22, 2008,
USA.
15. Neoadjuvant
Chemotherapy followed by Concurrent Chemoradiation in treatment of Locally
Advanced Nasopharyngeal Cancer, Gulf Journal of Oncology, Issue
3, January 2008.
16. FOLFOX and
Bevacizumab as First Line Treatment in Metastatic Colorectal Cancer: Phase II
Study, Kasr El Aini Journal Of Clinical Oncology and
Nuclear Medicine, Faculty of Medicine Cairo University, Vol. 3, No. 3-4,
July-Oct. 2007.
17. Liposomal
Doxorubicin in Relapsing Ovarian Carcinoma: Phase II Study, Kasr
El Aini Journal Of Clinical Oncology and Nuclear Medicine, Faculty of Medicine Cairo
University, Vol. 3, No. 3-4, July-Oct. 2007.
18. Outcome of Ablation of Thyroid Remnants with 100 mCi
(3.7 GBq) Iodine-131 in Patients with Thyroid Cancer, Medical
Journal of Cairo University, Vol. 75, No. 2, Suppl. June:187-191, 2007.
19. Quality
Management Program for Intra Vascular Brachytherapy: Poster presentation in Kasr El Aini Conference of Clinical
Oncology and Nuclear Medicine (NEMROCK), Cairo University, 1- 4 December
2006.
20. Color Doppler
Ultrasound as an Objective Assessment Tool for Response to Chemotherapy in
Locally Advanced Breast Cancer, Kasr El Aini Journal Of
Clinical Oncology and Nuclear Medicine, Faculty of Medicine Cairo
University, Vol. 2, No. 3-4, July-Oct. 2006.
21. Oxaliplatin and
Capecitabine in the Treatment of Metastatic Colorectal Cancer (Phase-II Study),
Kasr El Aini Journal of Clinical Oncology and Nuclear Medicine, Faculty of
Medicine Cairo University, Vol. 2, No. 3-4, July-Oct. 2006.
22. Primary Combined Chemotherapy in Locally Advanced or
Metastatic Parotid Carcinoma , Kasr El Aini Journal Of Clinical
Oncology and Nuclear Medicine, Faculty of Medicine, Cairo University , Vol
1, No. 2, October 2005 . 23. Role of Gemcitabine,
Oxaliplatin and Prednisolone Combination as First Line
Chemotherapy in Non-Hodgkin’s Lymphoma , Medical Journal Of Cairo
University , Faculty of Medicine, Cairo University, Vol. 73, No. 2, June 2005.
Any information uploaded, such as a resume, or input by the user is owned solely by the user, not LiveCareer. For further information, please visit our Terms of Use.
Resume Overview
School Attended
Kasr El-Aini School of Medicine
Kasr El-Aini School of Medicine
Kasr El-Aini School of Medicine
Job Titles Held:
Professor of Oncology
Assistant Professor
Lecturer
Assistant Lecturer
Oncology Fellow
Degrees
MBBCh
MSc
Ph.D.
In Clinical Oncology (Radiation Therapy and Medical Oncology), Faculty of Medicine, Kasr El-Aini, Cairo University in November, 1996 and was graded good.